echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Autoimmun: Renal and vascular outcomes in patients with nephropathy with simple antiphospholipid syndrome

    J Autoimmun: Renal and vascular outcomes in patients with nephropathy with simple antiphospholipid syndrome

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by a venous or arterial thromboembolic event or obstetric manifestation, with the persistence of at least one type of antiphospholipid antibody (aPL) (lupus anticoagulant, anticardiolipin antibody, or anti-beta2 glycoprotein 1 (anti-beta2GP1)


    Methods: A retrospective multicenter study


    Results: Including 30 patients (19 females), the median age was 40 years (34-52 years).


    Conclusion: The renal prognosis of isolated APSN is poor, and 6 patients develop ESRD


     

    Source: Rousselin C, Amoura Z, Faguer S, Bataille P, Boffa JJ, Canaud G, Guerrot D, Jourde-Chiche For The Gclr N, Karras A, Auxenfants E, Chapelet A, Lambert M, Behal H, Nochy D, Jean-Paul DVH, Brocheriou For The Cfpr I, Gnemmi V, Quemeneur T.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.